Cyclosporine in chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial
- 1 October 2006
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 55 (4), 705-709
- https://doi.org/10.1016/j.jaad.2006.04.078
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of lifeAnnals of Allergy, Asthma & Immunology, 2004
- CYCLOSPORIN A IN PATIENTS AFFECTED BY CHRONIC IDIOPATHIC URTICARIA: A THERAPEUTIC ALTERNATIVEImmunopharmacology and Immunotoxicology, 2001
- Randomized double-blind study of cyclosporin in chronic ‘idiopathic’ urticariaBritish Journal of Dermatology, 2000
- Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticariaJournal of the American Academy of Dermatology, 2000
- The extent and nature of disability in different urticarial conditionsBritish Journal of Dermatology, 1999
- Short-term oral cyclosporine for chronic idiopathic urticaria.Journal of the European Academy of Dermatology and Venereology, 1999
- Low‐dose cyclosporin A in the treatment of severe chronic idiopathic urticariaAllergy, 1997
- Cetirizine and astemizole therapy for chronic idiopathic urticaria: A double-blind, placebo-controlled, comparative trialJournal of the American Academy of Dermatology, 1995
- Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical useClinical and Experimental Dermatology, 1994
- Oral cyclosporine for severe chronic idiopathic urticaria and angioedemaJournal of the American Academy of Dermatology, 1991